Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel
Abstract Background mRNA technology is currently being investigated for a range of oncology indications. We assessed the willingness to pay (WTP) of the general population in Israel for a hypothetical novel mRNA-based treatment for oncology indications. Methods We used a contingent valuation methodo...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Israel Journal of Health Policy Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13584-024-00594-z |